Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Non-Current Assets (2018 - 2025)

TransMedics (TMDX) has 8 years of Non-Current Assets data on record, last reported at $430.6 million in Q4 2025.

  • For Q4 2025, Non-Current Assets rose 40.32% year-over-year to $430.6 million; the TTM value through Dec 2025 reached $1.4 billion, up 31.6%, while the annual FY2025 figure was $430.6 million, 40.32% up from the prior year.
  • Non-Current Assets reached $430.6 million in Q4 2025 per TMDX's latest filing, up from $333.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $430.6 million in Q4 2025 and bottomed at $5.1 million in Q3 2021.
  • Average Non-Current Assets over 5 years is $150.5 million, with a median of $90.1 million recorded in 2023.
  • Peak YoY movement for Non-Current Assets: decreased 2.56% in 2021, then skyrocketed 916.45% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $9.8 million in 2021, then skyrocketed by 95.34% to $19.2 million in 2022, then surged by 916.45% to $195.4 million in 2023, then skyrocketed by 57.05% to $306.9 million in 2024, then soared by 40.32% to $430.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $430.6 million in Q4 2025, $333.0 million in Q3 2025, and $332.4 million in Q2 2025.